Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT

scientific article published on 24 August 2016

Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00259-016-3490-6
P698PubMed publication ID27557844

P50authorKonstantin NikolaouQ35704652
Stephan KruckQ46767633
Christian la FougèreQ47460853
P2093author name stringArnulf Stenzl
Christina Pfannenberg
Gerald Reischl
Johannes Schwenck
Hansjoerg Rempp
P2860cites workOligometastases.Q55065168
In vivo visualization of prostate-specific membrane antigen in glioblastoma.Q55460684
Oligometastases revisitedQ56773912
Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted TherapyQ56969116
Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical ProstatectomyQ60606969
Processing of generator-produced 68Ga for medical application.Q64947317
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastasesQ77378855
Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasisQ81999680
Prostate-Specific Membrane Antigen PET/CT in Splenic SarcoidosisQ85228088
[(68)Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practiceQ85364606
[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomyQ34683467
Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acidQ35008067
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancerQ35043569
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancerQ37350456
Role of stereotactic body radiotherapy for oligometastasis from colorectal cancerQ37708013
Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis.Q38049420
The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysisQ38102842
Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis.Q38983173
68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imagingQ39389586
Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate CancerQ39636721
Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cellsQ40204286
Prostate specific membrane antigen (PSMA) expression gives prostate cancer cells a growth advantage in a physiologically relevant folate environment in vitroQ40312454
Radiation dosimetry and first therapy results with a (124)I/ (131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapyQ40529844
Survival outcomes for oligometastasis in resected non-small cell lung cancerQ40700961
Simultaneous (68)Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer.Q40959799
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 casesQ42456087
Impact of time-of-flight and point-spread-function in SUV quantification for oncological PET.Q43613277
Physical and clinical performance of the mCT time-of-flight PET/CT scannerQ43958296
More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancerQ44703542
Highly efficient automated synthesis of [(11)C]choline for multi dose utilizationQ44863225
High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancerQ44994966
Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysisQ46735738
Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation.Q46877983
The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.Q46984864
Is the standard uptake value (SUV) appropriate for quantification in clinical PET imaging? - Variability induced by different SUV measurements and varying reconstruction methods.Q51000563
68Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer.Q52985406
Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga-PSMA-positron emission tomography/computerized tomography.Q52991043
Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging.Q53023502
Combined PET/MRI improves diagnostic accuracy in patients with prostate cancer: a prospective diagnostic trial.Q53068179
(68)Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma.Q53068468
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.Q53131398
Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?Q53272044
[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients.Q53527477
P433issue1
P921main subjectprostate cancerQ181257
cancer metastasisQ120912394
P1104number of pages10
P304page(s)92-101
P577publication date2016-08-24
P1433published inEuropean Journal of Nuclear Medicine and Molecular ImagingQ15708890
P1476titleComparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT
P478volume44